Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 OncoCyteImmutepNovoheartVerseonBurcon NutraScience
SymbolNYSEAMERICAN:OCXASX:IMMCVE:NVHLON:VSNTSE:BU
Price Information
Current Price$2.18A$0.12N/AN/AC$0.84
52 Week RangeBuyN/AN/AN/ABuy
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/ABuy
Consensus Price Target$7.38N/AN/AN/AC$2.50
% Upside from Price Target238.30% upsideN/AN/AN/A197.62% upside
Trade Information
Market Cap$130.45 million$44.71 millionC$83.00 million£127.41 millionC$80.32 million
BetaN/AN/AN/AN/AN/A
Average Volume267,976N/A45,627560553,518
Sales & Book Value
Annual RevenueN/A$12.95 millionC$533,494.00N/AC$39,466.00
Price / SalesN/A3.450.00N/A2,035.15
CashflowN/AA$0.06 per shareN/AN/AC$0.08 per share
Price / CashN/A2.084.156.6111.18
Book ValueN/AA$0.07 per shareC$0.14 per shareGBX 21 per shareC$0.15 per share
Price / BookN/A1.600.00N/A5.49
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AA($0.04)C($0.04)GBX (14.30)C($0.06)
Trailing P/E Ratio0.00N/AN/AN/AN/A
Forward P/E Ratio∞∞N/AN/A∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A30.27%3.66%74.84%48.59%
Current RatioN/A6.77%8.51%3.36%10.75%
Quick RatioN/A6.37%6.04%3.09%10.39%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees12N/AN/AN/AN/A
Shares Outstanding62.47 million388.80 million188.64 million151.67 million95.62 million
Next Earnings Date5/12/2020 (Estimated)N/AN/AN/A7/7/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel